GLP-1s for Polyendocrine Metabolic Ovarian Syndrome Women with polyendocrine metabolic ovarian syndrome (PMOS) produce excess testosterone, which can lead to painful, heavy, or irregular periods, infertility, excess facial and body hair, severe acne, and small cysts on the ovaries
The frequency and reporting of these symptoms differ between individual medications within the class, so it's important to consult the specific SmPC for the prescribed product
To investigate whether responses to these two medication categories differ, we examined patient responses to each medication separately (Supplemental Fig
Despite FDA registration , they are not FDA approved , offer no medical care, lack clinical evidence for effectiveness, misuse GLP-1 terminology in marketing, and have mixed reviews with many users reporting no results
Precise Injection Strategy : Accurate injection placement is crucial to avoid nerve damage, blood vessel injury, or uneven fat distribution